Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.11 USD | +1.62% | -2.03% | +13.87% |
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Revenues | 14.15B | 11.14B | 17.46B | 31.88B | 37.28B | |||
Total Revenues | 14.15B | 11.14B | 17.46B | 31.88B | 37.28B | |||
Cost of Goods Sold, Total | 9.51B | 6.8B | 11.23B | 22.07B | 25.15B | |||
Gross Profit | 4.64B | 4.34B | 6.23B | 9.8B | 12.14B | |||
Selling General & Admin Expenses, Total | 7.92B | 5.95B | 7.1B | 7.89B | 7.04B | |||
R&D Expenses | 4.84B | 2.12B | 2.05B | 2.8B | 3.16B | |||
Depreciation & Amortization - (IS) | 472M | 575M | 902M | 947M | 823M | |||
Other Operating Expenses, Total | 13.23B | 8.65B | 10.06B | 11.64B | 11.02B | |||
Operating Income | -8.6B | -4.31B | -3.83B | -1.83B | 1.11B | |||
Interest Expense, Total | -559M | -458M | -483M | -565M | -633M | |||
Interest And Investment Income | 234M | 55M | 37M | 139M | 484M | |||
Net Interest Expenses | -325M | -403M | -446M | -426M | -149M | |||
Income (Loss) On Equity Invest. | -34M | -34M | -37M | 107M | 48M | |||
Currency Exchange Gains (Loss) | -40M | -128M | -67M | -147M | -182M | |||
Other Non Operating Income (Expenses) | 199M | 59M | -230M | -213M | -634M | |||
EBT, Excl. Unusual Items | -8.8B | -4.81B | -4.61B | -2.51B | 193M | |||
Restructuring Charges | - | -362M | - | - | - | |||
Impairment of Goodwill | - | -100M | - | - | - | |||
Gain (Loss) On Sale Of Investments | 2M | -1.82B | 1.63B | -6.82B | 1.97B | |||
Gain (Loss) On Sale Of Assets | - | 204M | 1.68B | 14M | 204M | |||
Asset Writedown | - | -70M | - | - | - | |||
Other Unusual Items | 327M | -23M | 242M | - | - | |||
EBT, Incl. Unusual Items | -8.47B | -6.98B | -1.06B | -9.32B | 2.37B | |||
Income Tax Expense | 45M | -192M | -492M | -181M | 213M | |||
Earnings From Continuing Operations | -8.51B | -6.79B | -570M | -9.14B | 2.16B | |||
Earnings Of Discontinued Operations | - | - | - | - | - | |||
Net Income to Company | -8.51B | -6.79B | -570M | -9.14B | 2.16B | |||
Minority Interest | 6M | 20M | 74M | -3M | -269M | |||
Net Income - (IS) | -8.51B | -6.77B | -496M | -9.14B | 1.89B | |||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||
Net Income to Common Incl Extra Items | -8.51B | -6.77B | -496M | -9.14B | 1.89B | |||
Net Income to Common Excl. Extra Items | -8.51B | -6.77B | -496M | -9.14B | 1.89B | |||
Per Share Items | ||||||||
Net EPS - Basic | -6.81 | -3.86 | -0.26 | -4.64 | 0.93 | |||
Basic EPS - Continuing Operations | -6.81 | -3.86 | -0.26 | -4.64 | 0.93 | |||
Basic Weighted Average Shares Outstanding | 1.25B | 1.75B | 1.89B | 1.97B | 2.04B | |||
Net EPS - Diluted | -6.81 | -3.86 | -0.28 | -4.65 | 0.87 | |||
Diluted EPS - Continuing Operations | -6.81 | -3.86 | -0.28 | -4.65 | 0.87 | |||
Diluted Weighted Average Shares Outstanding | 1.25B | 1.75B | 1.9B | 1.97B | 2.09B | |||
Normalized Basic EPS | -4.4 | -1.7 | -1.48 | -0.8 | -0.07 | |||
Normalized Diluted EPS | -4.4 | -1.7 | -1.48 | -0.8 | -0.07 | |||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||
Supplemental Items | ||||||||
EBITDA | -8.15B | -3.79B | -3B | -885M | 1.93B | |||
EBITA | -8.58B | -4.15B | -3.4B | -1.31B | 1.47B | |||
EBIT | -8.6B | -4.31B | -3.83B | -1.83B | 1.11B | |||
EBITDAR | -7.7B | -3.18B | -2.6B | -449M | 2.37B | |||
Effective Tax Rate - (Ratio) | -0.53 | 2.75 | 46.33 | 1.94 | 8.99 | |||
Current Domestic Taxes | 1M | 11M | 4M | 23M | 17M | |||
Current Foreign Taxes | 132M | 63M | 196M | 237M | 170M | |||
Total Current Taxes | 133M | 74M | 200M | 260M | 187M | |||
Deferred Domestic Taxes | -69M | -104M | -57M | -343M | 23M | |||
Deferred Foreign Taxes | -19M | -162M | -635M | -98M | 3M | |||
Total Deferred Taxes | -88M | -266M | -692M | -441M | 26M | |||
Normalized Net Income | -5.49B | -2.99B | -2.81B | -1.57B | -148M | |||
Interest on Long-Term Debt | 562M | 479M | 492M | 538M | 626M | |||
Supplemental Operating Expense Items | ||||||||
Advertising Expense | 1.3B | 992M | 1.7B | 1.7B | 1.7B | |||
Selling and Marketing Expenses | 4.63B | 3.56B | 4.79B | 4.76B | 4.36B | |||
General and Administrative Expenses | 3.3B | 2.39B | 2.32B | 3.14B | 2.68B | |||
Research And Development Expense From Footnotes | 4.86B | 2.26B | 2.12B | 2.8B | 3.16B | |||
Net Rental Expense, Total | 447M | 606M | 397M | 436M | 438M | |||
Imputed Operating Lease Interest Expense | 262M | 245M | 140M | 169M | 188M | |||
Imputed Operating Lease Depreciation | 185M | 361M | 257M | 267M | 250M | |||
Stock-Based Comp., COGS (Total) | 454M | 72M | 139M | 154M | 184M | |||
Stock-Based Comp., R&D Exp. (Total) | 2.96B | 477M | 614M | 1.06B | 1.22B | |||
Stock-Based Comp., S&M Exp. (Total) | 242M | 48M | 83M | 102M | 96M | |||
Stock-Based Comp., G&A Exp. (Total) | 942M | 230M | 332M | 477M | 440M | |||
Total Stock-Based Compensation | 4.6B | 827M | 1.17B | 1.79B | 1.94B |